Recombinant multi-species PIGA protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis
Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine PIGA protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
This gene encodes a protein required for synthesis of N-acetylglucosaminyl phosphatidylinositol (GlcNAc-PI), the first intermediate in the biosynthetic pathway of GPI anchor. The GPI anchor is a glycolipid found on many blood cells and which serves to anchor proteins to the cell surface. Paroxysmal nocturnal hemoglobinuria, an acquired hematologic disorder, has been shown to result from mutations in this gene. Alternate splice variants have been characterized. A related pseudogene is located on chromosome 12. [provided by RefSeq, Jun 2010]
The Alternative Names of target: GPI3,GlcNAc-PI synthesis protein,MCAHS2,NEDEPH,PIG-A,PIGA,PNH1,Phosphatidylinositol N-acetylglucosaminyltransferase subunit A,Phosphatidylinositol-glycan biosynthesis class A protein (PIG-A),Pig-a,Piga
Go
to PIGA products collection
>>
(antibodies,
antigen, VLP, mRNA, ORF viral vector, etc)
Product information
| Catalog No. | Product Name | Species Reactivity |
|---|---|---|
| GM-Tg-hg-IP1386-Ag-1/ GM-Tg-hg-IP1386-Ag-2 | Human PIGA protein | Human |
| GM-Tg-rg-IP1386-Ag-1/ GM-Tg-rg-IP1386-Ag-2 | Rat PIGA protein | Rat |
| GM-Tg-mg-IP1386-Ag-1/ GM-Tg-mg-IP1386-Ag-2 | Mouse PIGA protein | Mouse |
| GM-Tg-cynog-IP1386-Ag-1/ GM-Tg-cynog-IP1386-Ag-2 | Cynomolgus/Rhesus macaque PIGA protein | Cynomolgus/ Rhesus macaque |
| GM-Tg-felg-IP1386-Ag-1/ GM-Tg-felg-IP1386-Ag-2 | Feline PIGA protein | Feline |
| GM-Tg-cang-IP1386-Ag-1/ GM-Tg-cang-IP1386-Ag-2 | Canine PIGA protein | Canine |
| GM-Tg-bovg-IP1386-Ag-1/ GM-Tg-bovg-IP1386-Ag-2 | Bovine PIGA protein | Bovine |
| GM-Tg-equg-IP1386-Ag-1/ GM-Tg-equg-IP1386-Ag-2 | Equine PIGA protein | Equine |
Size: 1mg | 10mg | 100mg
Product Description
| Catalog No. |
GM-Tg-hg-IP1386-Ag-1/ GM-Tg-hg-IP1386-Ag-2;
GM-Tg-rg-IP1386-Ag-1/ GM-Tg-rg-IP1386-Ag-2;
GM-Tg-mg-IP1386-Ag-1/ GM-Tg-mg-IP1386-Ag-2; GM-Tg-cynog-IP1386-Ag-1/ GM-Tg-cynog-IP1386-Ag-2; GM-Tg-felg-IP1386-Ag-1/ GM-Tg-felg-IP1386-Ag-2; GM-Tg-cang-IP1386-Ag-1/ GM-Tg-cang-IP1386-Ag-2; GM-Tg-bovg-IP1386-Ag-1/ GM-Tg-bovg-IP1386-Ag-2; GM-Tg-equg-IP1386-Ag-1/ GM-Tg-equg-IP1386-Ag-2 |
| Products Name | PIGA protein |
| Species | Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine |
| Target Name | PIGA |
| Protein Sub-location | Introcelluar Protein |
| Isotypes | Recombinant protein |
| Expression platform | Mammalian cell |
| Bioactivity validation | Affintiy&bioactivity validated by ELISA, cell culture validated. |
| Tag | His |
| Products description | Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine PIGA protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic). |
| Purity | Purity: ≥95% (SDS-PAGE) |
| Application | In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
| Formulation & Reconstitution |
Lyophilized from GM's Protein Stability Buffer2
(PSB2,Confidential Ingredients) or PBS
(pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
| Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
About Gmab

GMab, developed by GeneMedi, constitutes an
advanced library of recombinant
monoclonal antibodies, each meticulously
designed to target specific molecular
entities. Leveraging the sophisticated
capabilities of GM’s Taurus™ and LIBRA™
platforms, GMab synthesizes antibodies
characterized by high binding affinity,
exceptional physicochemical stability, and
optimal developability profiles.
Through
expression in mammalian cell lines, GMab has
been established as a paradigmatic
reference antibody. It holds significance in
myriad domains of biological drug
discovery, encompassing cellular cultivation,
innovative assay methodologies,
strategic animal model systematization, in-depth
pharmacokinetic & pharmacodynamic
(PK/PD) modeling, and intricate mechanism of
action (MOA) investigations.